BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Broad U.S. Method Patent Issued To Archus Orthopedics, Inc.


8/10/2006 11:57:12 AM

REDMOND, Wash., Aug. 10 /PRNewswire/ -- Archus Orthopedics, Inc. today announced that it has been awarded its seventh United States Patent. Arising from a 1999 patent application filed by the company's founder, Mark Reiley, M.D., U.S. Patent 7,087,084 discloses the surgical method of removing some or all of a natural facet joint and replacing it with a prosthesis anchored in the pedicle.

"The pedicle is used as the site for fixation of a variety of posterior spine implants because it is a very strong anchoring point," said Jim Fitzsimmons, chairman and chief executive officer, commenting on the patent issuance. "This patent, in combination with Archus' existing U.S. and foreign patents, extends our dominant position in the facet joint replacement market worldwide," he added.

Archus is currently conducting a U.S. clinical trial of its Total Facet Arthroplasty System(TM) "TFAS(R)", a novel spinal implant designed to treat spinal stenosis, a condition in which degenerative changes in the facet joints result in compression of spinal nerves producing neurological symptoms in the legs. Traditionally, patients with spinal stenosis undergo decompressive laminectomy surgery, which is often accompanied by spinal fusion. The TFAS(R) replaces the degenerative facet joints with a prosthetic joint implant intended to restore stability and normal motion to the spine, eliminating the need for fusion.

In addition to TFAS(R), Archus is developing a suite of products to address other important and attractive applications for facet joint replacement. "Given its fundamental breadth, we believe that this patent will be applicable across our growing product line," said Fitzsimmons.

About Archus Orthopedics

Founded in July 2001, Archus Orthopedics is a privately held company developing a family of reconstructive implants to treat a variety of spine disorders resulting from degenerative changes in the facet joints. Archus has received venture capital funding from MPM Capital, InterWest Partners and Polaris Venture Partners. In January 2006, the company announced completion of a $35 Million financing led by Johnson & Johnson Development Corporation in cooperation with DePuy Spine.

Archus Orthopedics, Inc.

CONTACT: Jim Fitzsimmons, Chairman and Chief Executive Officer of ArchusOrthopedics, Inc., +1-425-284-3650, or jfitzsimmons@archususa.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES